Showing results (791-800 of 4,513) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|September 23, 2021
Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myelomaRahul Banerjee, Mimi Lo, Thomas G MartinFuture Oncology (London, England)|May 30, 2019
Diagnostic and prognostic significance of serum CD26 level in Asian women with high-grade serous ovarian carcinomaShiqing Shao, Chen Wang, Jun Tian, et al.Future Oncology (London, England)|October 16, 2018
Cost-utility of afatinib and gefitinib as first-line treatment for EGFR-mutated advanced non-small-cell lung cancerHao Wang, Chenxin Zeng, Xin Li, et al.Future Oncology (London, England)|September 15, 2018
Pre-emptive skin treatments to prevent skin toxicity caused by anti-EGFR antibody: the real-world evidence in JapanNaoya Yamazaki, Yumi Oomuku, Izumi Mishiro, et al.Future Oncology (London, England)|June 19, 2019
RGB-02 (biosimilar pegfilgrastim) in the treatment of chemotherapy-induced neutropeniaDóra Sántha, András Illés, Ildikó Aradi, et al.Future Oncology (London, England)|August 25, 2018
Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinomaLei Zhang, Qing-Gen Chen, Shu-Qi Li, et al.Future Oncology (London, England)|August 25, 2018
Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markersYanyan Li, Aaron Domina, Gi Lim, et al.Future Oncology (London, England)|August 30, 2018
Mammaprint™: a comprehensive reviewMariana Brandão, Noam Pondé, Martine Piccart-GebhartFuture Oncology (London, England)|June 27, 2019
Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysisJiaqing Liu, Huaqiang Zhou, Yaxiong Zhang, et al.Future Oncology (London, England)|June 26, 2019
Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinomaOmar Abdel-RahmanPageof 452